Day: February 21, 2026

health news

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Staff February 21, 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease...

Read MoreRead more about Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

You may have missed

health news

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Staff November 14, 2026
health news

Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress

Staff November 14, 2026
health news

BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update

Staff November 14, 2026
health news

Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Staff November 14, 2026
health news

Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update

Staff November 14, 2026
error: Content is protected !!